LINC01412

Across TCGA pan-cancer cohorts, LINC01412 RNA differs between tumor and matched normal tissue in 14 of 18 cancer types tested, making tumor–normal expression one of LINC01412’s most consistent transcriptional readouts.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where LINC01412 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC01412 is over-expressed in tumor, although a few such as BLCA and LUAD show the opposite, repressed pattern.

BLCA, LUAD, and THCA are the cancer types where LINC01412 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01412 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BLCA	Male	IV	−0.892	<.001	11	view →
LUAD	Female	II,III,IV	−0.994	<.001	9	view →
THCA	Male	III,IV	−0.517	<.001	9	view →
COAD	Male	II,III,IV	−0.368	<.001	9	view →
LUSC	Male	II,III,IV	−1.079	<.001	8	view →
KICH	All	All	−0.486	<.001	8	view →
HNSC	All	All	−0.112	.003	7	view →
UCEC	All	All	−0.641	<.001	6	view →
BRCA	Female	II,III,IV	−0.605	<.001	6	view →
KIRP	Male	All	−0.310	<.001	5	view →
KIRC	Female	IV	−0.279	.028	4	view →
READ	All	All	−0.513	.014	3	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 14 lineages.

LINC01412–BLCA

Open the BLCA breakdown →